Ab
Abdi Ibrahim
Istanbul TRFounded 19125,000 employees
Private CappharmaPrivateOncologyCardiology
Platform: Turkish Pharma
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ABD-5382 | ABD-5382 | Preclinical | 1 | CD38 | Prostate CaACC | ||
| Lisotapinarof | ABD-646 | NDA/BLA | 2 | CD38 | CFNMOSD | ||
| ABD-3507 | ABD-3507 | Preclinical | 2 | VEGF | DravetMigraine | ||
| Adagranesiran | ABD-9046 | Phase 2 | 1 | USP1 | LGS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)